Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria

Area of Science:

• Immunology
• Infectious Diseases
• Malariology

Background:

• Tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1beta, and IL-6 are key in severe Plasmodium falciparum malaria pathogenesis.
• Interleukin-10 (IL-10) is a crucial immunomodulatory cytokine.

Purpose of the Study:

• To investigate the effect of IL-10 on pro-inflammatory cytokine production by peripheral blood mononuclear cells (PBMC) in Plasmodium falciparum malaria.
• To determine if IL-10 counter-regulates cytokine responses in malaria patients.

Main Methods:

• Peripheral blood mononuclear cells (PBMC) from malaria patients were stimulated with malarial antigens.
• Exogenous IL-10 or anti-IL-10 antibodies were added to PBMC cultures.
• Cytokine mRNA accumulation and protein levels were measured using quantitative assays.
• Kinetic studies analyzed the temporal production of cytokines and IL-10.

Main Results:

• Exogenous IL-10 significantly inhibited malarial antigen-induced TNF-alpha, IL-1beta, and IL-6 production by reducing mRNA.
• Maximal inhibition by IL-10 occurred when added within the first 2 hours of stimulation.
• Anti-IL-10 antibody addition markedly enhanced pro-inflammatory cytokine production.
• The inhibitory effect of IL-10 was more pronounced in patients with uncomplicated malaria compared to severe malaria.
• Severe malaria PBMC showed a weaker response to IL-10, suggesting impaired negative feedback.

Conclusions:

• IL-10 acts as a negative regulator of the pro-inflammatory cytokine response to Plasmodium falciparum infection.
• Severe falciparum malaria is potentially associated with an inadequate IL-10-mediated negative feedback mechanism.
• Dysregulation of IL-10 signaling may contribute to the pathogenesis of severe malaria.